Terms: = Germ cell tumor AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Treatment
37 results:
1. foxo1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
Pintor S; Lopez A; Flores D; Lozoya B; Soti B; Pokhrel R; Negrete J; Persans MW; Gilkerson R; Gunn B; Keniry M
FEBS Open Bio; 2023 Nov; 13(11):2108-2123. PubMed ID: 37584250
[TBL] [Abstract] [Full Text] [Related]
2. In silico and in vitro analyses of a novel foxo1 agonist reducing Aβ levels via downregulation of BACE1.
Lv MT; Wang HC; Meng XW; Shi YT; Zhang YM; Shan LL; Shi RL; Ni TJ; Duan YC; Yang ZJ; Zhang W
CNS Neurosci Ther; 2024 Mar; 30(3):e14140. PubMed ID: 36892036
[TBL] [Abstract] [Full Text] [Related]
3. The role of EZH2 as a potential therapeutic target in retinoblastoma.
Zhao Y; Cheng Y; Qu Y
Exp Eye Res; 2023 Feb; 227():109389. PubMed ID: 36669714
[TBL] [Abstract] [Full Text] [Related]
4. The foxo1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells.
Flores D; Lopez A; Udawant S; Gunn B; Keniry M
FEBS Open Bio; 2023 Feb; 13(2):352-362. PubMed ID: 36602390
[TBL] [Abstract] [Full Text] [Related]
5. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of glioblastoma progression by Urolithin A in vitro and in vivo by regulating Sirt1-foxo1 axis via ERK/AKT signaling pathways.
Liu CL; Zhao D; Li JJ; Liu S; An JJ; Wang D; Hu FA; Qiu CY; Cui MH
Neoplasma; 2022 Jan; 69(1):80-94. PubMed ID: 34818027
[TBL] [Abstract] [Full Text] [Related]
7. XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor.
Pan L; Cheng C; Duan P; Chen K; Wu Y; Wu Z
J Exp Clin Cancer Res; 2021 Aug; 40(1):255. PubMed ID: 34384466
[TBL] [Abstract] [Full Text] [Related]
8. Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma.
Körholz K; Ridinger J; Krunic D; Najafi S; Gerloff XF; Frese K; Meder B; Peterziel H; Vega-Rubin-de-Celis S; Witt O; Oehme I
Cells; 2021 Apr; 10(5):. PubMed ID: 33923163
[TBL] [Abstract] [Full Text] [Related]
9. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma cell Line.
Nozhat Z; Zarkesh M; Baldini E; Mohammadi-Yeganeh S; Azizi F; Hedayati M
Anticancer Agents Med Chem; 2022; 22(4):713-720. PubMed ID: 33461474
[TBL] [Abstract] [Full Text] [Related]
10. Downregulation of MEG3 promotes neuroblastoma development through foxo1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition.
Ye M; Lu H; Tang W; Jing T; Chen S; Wei M; Zhang J; Wang J; Ma J; Ma D; Dong K
Int J Biol Sci; 2020; 16(15):3050-3061. PubMed ID: 33061817
[TBL] [Abstract] [Full Text] [Related]
11. Cold Atmospheric Plasma and Silymarin Nanoemulsion Activate Autophagy in Human Melanoma cells.
Adhikari M; Adhikari B; Ghimire B; Baboota S; Choi EH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178401
[TBL] [Abstract] [Full Text] [Related]
12. The PI3K pathway impacts stem gene expression in a set of glioblastoma cell lines.
Martinez E; Vazquez N; Lopez A; Fanniel V; Sanchez L; Marks R; Hinojosa L; Cuello V; Cuevas M; Rodriguez A; Tomson C; Salinas A; Abad M; Holguin M; Garza N; Arenas A; Abraham K; Maldonado L; Rojas V; Basdeo A; Schuenzel E; Persans M; Innis-Whitehouse W; Keniry M
J Cancer Res Clin Oncol; 2020 Mar; 146(3):593-604. PubMed ID: 32030510
[TBL] [Abstract] [Full Text] [Related]
13. MiR-223-3p promotes the growth and invasion of neuroblastoma cell via targeting foxo1.
Han LL; Zhou XJ; Li FJ; Hao XW; Jiang Z; Dong Q; Chen X
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8984-8990. PubMed ID: 31696486
[TBL] [Abstract] [Full Text] [Related]
14. miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma cells Through Upregulation of foxo1.
Ni W; Luo L; Zuo P; Li R; Xu X; Wen F; Hu D
Oncol Res; 2019 Jun; 27(6):703-712. PubMed ID: 30841958
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant Active cis-Regulatory Elements Associated with Downregulation of RET Finger Protein Overcome Chemoresistance in Glioblastoma.
Ranjit M; Hirano M; Aoki K; Okuno Y; Ohka F; Yamamichi A; Kato A; Maeda S; Motomura K; Matsuo K; Enomoto A; Ino Y; Todo T; Takahashi M; Wakabayashi T; Kato T; Natsume A
Cell Rep; 2019 Feb; 26(9):2274-2281.e5. PubMed ID: 30811978
[TBL] [Abstract] [Full Text] [Related]
16. foxo1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma.
Chen C; Han G; Li Y; Yue Z; Wang L; Liu J
J Cell Biochem; 2019 Jan; 120(1):882-893. PubMed ID: 30216501
[TBL] [Abstract] [Full Text] [Related]
17. FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma.
Wang L; Wang J; Jin T; Zhou Y; Chen Q
Biochem Biophys Res Commun; 2018 Sep; 504(1):46-53. PubMed ID: 30172378
[TBL] [Abstract] [Full Text] [Related]
18. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract] [Full Text] [Related]
19. Propofol Prevents the Progression of Malignant Pheochromocytoma In Vitro and In Vivo.
Wang H; Zhang S; Zhang A; Yan C
DNA Cell Biol; 2018 Apr; 37(4):308-315. PubMed ID: 29565198
[TBL] [Abstract] [Full Text] [Related]
20. N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of foxo1 in an Akt-dependent manner.
Scheffel MJ; Scurti G; Wyatt MM; Garrett-Mayer E; Paulos CM; Nishimura MI; Voelkel-Johnson C
Cancer Immunol Immunother; 2018 Apr; 67(4):691-702. PubMed ID: 29396710
[TBL] [Abstract] [Full Text] [Related]
[Next]
